Literature DB >> 19500732

Cellular mechanisms of Barrett's esophagus development.

Mariagnese Barbera1, Rebecca C Fitzgerald.   

Abstract

Barrett's esophagus (BE) is a metaplastic premalignant disorder in which the normal stratified squamous epithelium of the lower esophagus is replaced by a columnar lined epithelium with intestinal differentiation. BE generally occurs in the context of chronic gastroesophageal reflux disease and it is the primary risk factor for the development of esophageal adenocarcinoma, with a conversion rate of 0.5% to 1% per annum. The dramatic increase of esophageal adenocarcinoma incidence in the western world over the last two decades justifies the strong interest in BE and its development with the aim to improve preventative and therapeutic clinical strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19500732     DOI: 10.1016/j.soc.2009.03.001

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  7 in total

Review 1.  Future approaches for inner ear protection and repair.

Authors:  Seiji B Shibata; Yehoash Raphael
Journal:  J Commun Disord       Date:  2010-04-08       Impact factor: 2.288

2.  Stromal directives can control cancer.

Authors:  Thea D Tlsty; Philippe Gascard
Journal:  Science       Date:  2019-07-12       Impact factor: 47.728

Review 3.  Gastric epithelial stem cells.

Authors:  Jason C Mills; Ramesh A Shivdasani
Journal:  Gastroenterology       Date:  2010-12-07       Impact factor: 22.682

4.  Transgenic overexpression of cdx1b induces metaplastic changes of gene expression in zebrafish esophageal squamous epithelium.

Authors:  Bo Hu; Hao Chen; Xiuping Liu; Chengjin Zhang; Gregory J Cole; Ju-Ahng Lee; Xiaoxin Chen
Journal:  Zebrafish       Date:  2013-05-14       Impact factor: 1.985

5.  Role of XPC, XPD, XRCC1, GSTP genetic polymorphisms and Barrett's esophagus in a cohort of Italian subjects. A neural network analysis.

Authors:  Claudia Tarlarini; Silvana Penco; Massimo Conio; Enzo Grossi
Journal:  Clin Exp Gastroenterol       Date:  2012-08-08

6.  Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.

Authors:  N Carrossini; N Meireles Da Costa; E Andrade-Barreto; V P L Sousa; P Nicolau-Neto; P T Souza-Santos; G R Mansur; L Wernersbach; P T Bozza; J P B Viola; Luis Felipe Ribeiro Pinto
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

7.  DNA Damage in CD133-Positive Cells in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Raynoo Thanan; Ning Ma; Yusuke Hiraku; Katsunori Iijima; Tomoyuki Koike; Tooru Shimosegawa; Mariko Murata; Shosuke Kawanishi
Journal:  Mediators Inflamm       Date:  2016-03-10       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.